Inborn oxidative phosphorylation defect as risk factor for propofol infusion syndrome.
Vanlander AV, Jorens PG, Smet J, De Paepe B, Verbrugghe W, Van den Eynden GG, Meire F, Pauwels P, Van der Aa N, Seneca S, Lissens W, Okun JG, Van Coster R.
Vanlander AV, et al. Among authors: verbrugghe w.
Acta Anaesthesiol Scand. 2012 Apr;56(4):520-5. doi: 10.1111/j.1399-6576.2011.02628.x. Epub 2012 Jan 19.
Acta Anaesthesiol Scand. 2012.
PMID: 22260353